L, S., M, R., JF, L., DK, Y., D, P., J, G., . . . R, R. (2026). Relationships between botulinum toxin type, administer and location with odds of adverse events. Clinical and experimental dermatology, 51(8), 1427. https://doi.org/10.1093/ced/llag124
Chicago Style (17th ed.) CitationL, Smith, et al. "Relationships Between Botulinum Toxin Type, Administer and Location with Odds of Adverse Events." Clinical and Experimental Dermatology 51, no. 8 (2026): 1427. https://doi.org/10.1093/ced/llag124.
MLA (9th ed.) CitationL, Smith, et al. "Relationships Between Botulinum Toxin Type, Administer and Location with Odds of Adverse Events." Clinical and Experimental Dermatology, vol. 51, no. 8, 2026, p. 1427, https://doi.org/10.1093/ced/llag124.
Warning: These citations may not always be 100% accurate.